News

Industry veteran Catherine Owen Adams expects external innovation will be key to getting the brain-focused drug developer to “the next level.” ...
The brain drug developer is now saying that its two marketed products could ultimately bring in $2 billion annually, and its ...
Dr Rajvi Mehta, a senior Iyengar yoga teacher, is the driving force behind this move and is ably supported by a band of equally selfless yoga teachers and students. Every year, Mehta organises an ...
Cite this: Rasagiline: A Second-Generation Monoamine Oxidase Type-B Inhibitor for the Treatment of Parkinson's Disease - Medscape - May 15, 2006.
The U.S. Supreme Court on Friday ruled against a firefighter who retired early because of Parkinson’s disease and alleged the city of Sanford violated the Americans with Disabilities Act by limiting a ...
The U.S. Supreme Court on Friday ruled against a Florida firefighter who retired early because of Parkinson’s disease and alleged the city of Sanford violated the Americans with Disabilities Act ...
Scientists believe people with Parkinson’s have different levels of certain compounds in their sebum, an oily substance produced by glands in the skin. Now another potential method building on ...
Michelle Madrigal got candid about the "emotional rollercoaster" she has been experiencing as she tries to get pregnant while dealing with Hashimoto’s disease and endometriosis. The ...
Argument An expert’s point of view on a current event. ‘Andor’ Is a Lesson in Building Rebellion ‘Star Wars’ proves a surprisingly rich text for insurgency.
The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and ...